US 8,822,438 B2
Methods and compositions for treating cancerGeneral
US 8,822,438 B2
Methods and compositions for treating cancer
Tech Center:
1600 Biotechnology and Organic Chemistry
Examiner:
San-Ming Hui
Art Unit:
1627 Organic Chemistry
Agent:
Auerbach; Alan H.||Belldegrum; Arie S.
Inventors:
Alan H. Auerbach; Arie S. Belldegrum
Assignee:
INSTITUTE OF CANCER RESEARCH
Priority:
08/25/06
Filed:
02/24/11
Granted:
09/02/14
Expiration:
08/25/26
Abstract
Methods and compositions for treating cancer are described herein. More particularly, the methods for treating cancer comprise administering a 17α-hydroxylase/C17,20-lyase inhibitor, such as abiraterone acetate (i.e., 3β-acetoxy-17-(3-pyridyl)androsta-5,16-diene), in combination with at least one additional therapeutic agent such as an anti-cancer agent or a steroid. Furthermore, disclosed are compositions comprising a 17α-hydroxylase/C17,20-lyase inhibitor, and at least one additional therapeutic agent, such as an anti-cancer agent or a steroid.
Cooperative Patent Classification (CPC)
A61A61K31/573A61P35/00A61K